Fidelity Management & Research Company

Develops programmable epigenetic medicines to treat genetic diseases like FSHD

Fabless semiconductor company building connectivity chips for hyperscale, edge, and AI data centers

Develops lead-212 targeted alpha therapies to treat cancer

Develops allogeneic, off-the-shelf CAR-T cell therapies for hematological malignancies

Develops advanced 3D scanning probe metrology and inspection systems for semiconductor manufacturing

Develops next-generation RNAi therapeutics and engineering platform for multiple disease areas

Develops inobrodib, a first-in-class oral p300/CBP inhibitor for relapsed or refractory multiple myeloma

Builds and operates small GEO satellites for commercial and government communications

Develops advanced thermal cooling technologies for AI data centers and edge devices

Develops commercial fusion technology for neutron testing radioisotope production and fusion energy

Builds the fastest AI infrastructure in the world

Develops automated flight control systems for aircraft

Provides autonomous drone delivery and logistics services

Provides cloud storage for AI-first applications

Develops next-generation therapies for immune-mediated inflammatory and fibrotic diseases

Develops medicines targeting historically undruggable protein targets in cancer

Builds perception systems for Physical AI operating in complex environments